DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery

Information source: Nanjing Medical University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Acute Coronary Syndrome; Coronary Artery Disease

Intervention: Nicardipine , Esmolol (Drug)

Phase: Phase 4

Status: Not yet recruiting

Sponsored by: Nanjing Medical University

Official(s) and/or principal investigator(s):
Shao-liang Chen, Director, Study Chair, Affiliation: Nanjing First Hospital,Nanjing Medical University

Overall contact:
Shaoliang Chen, Director, Phone: +86-25-52208048, Email: chmengx@126.com

Summary

Both calcium channel antagonist and beta-blocker have cardioprotective effect. Endothelial shear stress is predictive factor of clinical outcomes in patients with obstructive stenosis. The present study aims at comparing the re-distribution of shear stress and blood velocity during whole cardiac cycle after trans-coronary injection of Nicardipine and esmolol.

Clinical Details

Official title: Nanjing First Hospital, Nanjing Medical University

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Endothelial shear stress assessed by computational fluid dynamics

Secondary outcome: Minimal lumen area by intravascular ultrasound

Detailed description: Blood flow-induced endothelial shear stress has strong effect on endothelial function and development or progression of plaque formation. It is extensively accepted that low and/or oscillating shear stress causes endothelial dysfunction and is one of crucial factors in localizing early atherosclerosis .In contrary, normal and high shear stress is atheroma protective and is involved in compensatory remodeling . Most studies reported that the endothelial shear stress distribution in often idealized geometrical models of human coronary arteries was the subject of numerous investigations , and in these studies it was shown that the geometry of coronary arteries is the main determinant of the observed shear stress distribution. Generally, downstream of a plaque, low shear stress can be expected, Several cardiovascular active drugs have been shown to be cardio-protective for patients with obstructive coronary disease. Of these drugs, calcium channel blocker is one of most prescribed in everyday clinical practice. Ninomiya et al. reported calcium channel blocker was associated with increased coronary diameter and blood fluid with dose-dependent pattern in patients with normal or mild stenotic coronary artery. However, no reports on the dynamic

change of endothelial shear stress after calcium channel blocker in - vitron were published

so far. As a result, the aim of this study was to evaluate the effect of intra-venous injection of Nicardipine, one calcium channel blocker with shorter half-time, on the re-distribution of endothelial shear stress in patients with acute coronary syndrome and mild stenotic (<50%) coronary artery disease.

Eligibility

Minimum age: 18 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Diagnosis of unstable angina and non-Q wave myocardial infarction

- Age 18-75 yr.

- Diameter stenosis of coronary artery<70% diameter stenosis by visual estimation

- Blood pressure >110/70 mmHg

- Heart rate 60-~100 bpm, No cardiac arrhythmias

Exclusion Criteria:

- St-elevation myocardial infarction

- Lower blood pressure(<100/70mmHg)

- Heart rate <60 or >100 bpm, The presence of cardiac arrhythmias

- Allergy to study drugs

- Women in pregnancy

- Liver dysfunction

- Creatinine >2. 5mg/dl

- Bleeding stroke within 6 months

- Left ventricular ejection fraction<30% before maximal medication

Locations and Contacts

Shaoliang Chen, Director, Phone: +86-25-52208048, Email: chmengx@126.com

Nanjing First Hospital,Nanjing Medical University, Nanjing, Jiangsu 210006, China; Not yet recruiting
Shao-liang Chen, Director, Phone: +86-25-52208048, Email: chmengx@126.com
Additional Information

Starting date: October 2010
Last updated: July 28, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017